FMP012
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FMP012, covering 2017-10-13 to 2021-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults [Phase 1]